Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Total Debt: 2020-2024

Historic Total Debt for Eton Pharmaceuticals (ETON) over the last 5 years, with Dec 2024 value amounting to $29.8 million.

  • Eton Pharmaceuticals' Total Debt rose 636.17% to $30.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year increase of 261.40%. This contributed to the annual value of $29.8 million for FY2024, which is 454.11% up from last year.
  • According to the latest figures from FY2024, Eton Pharmaceuticals' Total Debt is $29.8 million, which was up 454.11% from $5.4 million recorded in FY2023.
  • Eton Pharmaceuticals' Total Debt's 5-year high stood at $29.8 million during FY2024, with a 5-year trough of $280,000 in FY2020.
  • Moreover, its 3-year median value for Total Debt was $5.4 million (2023), whereas its average is $12.1 million.
  • Per our database at Business Quant, Eton Pharmaceuticals' Total Debt declined by 27.15% in 2022 and then soared by 454.11% in 2024.
  • Over the past 5 years, Eton Pharmaceuticals' Total Debt (Yearly) stood at $280,000 in 2020, then spiked by 406.43% to $1.4 million in 2021, then fell by 27.15% to $1.0 million in 2022, then surged by 420.81% to $5.4 million in 2023, then soared by 454.11% to $29.8 million in 2024.